Bromide

Bromide

SCHEMBL23852358

CCCCC[P+](c1ccc(C)cc1)(c1ccc(C)cc1)c1ccc(C)cc1.[Br-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.33
BDKRB2 P30411 3/20 0.40
HTT P42858 1/20 0.39
DNM1 Q05193 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
TLR8 Q9NR97 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
HIF1A Q16665 1/20 0.34
MCHR1 Q99705 1/20 0.34
TRAP1 Q12931 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRM2 Q14416 1/20 0.33
GCGR P47871 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL23853413 0.96 HTT (0.39) BDKRB2HTTDNM1L3MBTL1TLR8
Hydrochloric Acid SCHEMBL23852343 0.96 BDKRB2 (0.40) BDKRB2HTTDNM1L3MBTL1TLR8
Hydrochloric Acid SCHEMBL6310910 0.94 HTT (0.42) BDKRB2HTTDNM1L3MBTL1TLR8
Bromide SCHEMBL7196672 0.94 HRH3 (0.39) BDKRB2HTTDNM1L3MBTL1TLR8
Bromide SCHEMBL7611775 0.91 HIF1A (0.47) HTTDNM1HIF1ATRAP1
Bromide SCHEMBL131195 0.81 HIF1A (0.58) BDKRB2DNM1HIF1ATRAP1
Bromide SCHEMBL23038696 0.81 TRAP1 (0.34) TRAP1
Bromide SCHEMBL1866839 0.79 HIF1A (0.56) DNM1HIF1ATRAP1
Bromide SCHEMBL7759526 0.79 HIF1A (0.56) DNM1HIF1ATRAP1
Bromide SCHEMBL164301 0.79 HIF1A (0.56) DNM1HIF1ATRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3885334-B1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHINETSU CHEMICAL CO (JP) 2023-01-11 EP disclosed
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-23 US disclosed
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-30 US disclosed
EP-3885334-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 2021-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME ADH1C, ORC3, ADH1A ACHE 1699/4885BDKRB2 1197/4885HTT 4482/4885
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same ADH1C, ORC3, ADH1A ACHE 1699/4885BDKRB2 1197/4885HTT 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.